Bradley L. Campbell - Mar 15, 2022 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Chief Operating Officer, Director
Signature
/s/ Christian Formica, Attorney-in-Fact
Stock symbol
FOLD
Transactions as of
Mar 15, 2022
Transactions value $
$0
Form type
4
Date filed
4/8/2022, 07:31 PM
Previous filing
Jan 19, 2022
Next filing
Mar 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Award +105K +17.88% 690K Mar 15, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Award $0 +188K $0.00 188K Mar 15, 2022 Common Stock 188K $8.95 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock.
F2 The Restricted Stock Units will vest in four equal annual installments beginning on March 15, 2023.
F3 These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.

Remarks:

These equity awards represent Mr. Campbell's promotional grant as previously disclosed on the Form 8-K filed with the SEC on February 24, 2022.